Detalles de la búsqueda
1.
Pre-exposure prophylaxis with Evusheld™ elicits limited neutralizing activity against the omicron variant in kidney transplant patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272669
2.
Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272575
3.
Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20132449
4.
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21266252
5.
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-156166
6.
Sex differences in the decline of neutralizing antibodies to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20230466
7.
In-depth virological assessment of kidney transplant recipients with COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20132076
8.
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20101832
9.
Evolution of human antibody responses up to one year after SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256823
10.
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-445838
11.
Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21252532
Resultados
1 -
11
de 11
1
Próxima >
>>